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Introduction
Intra-articular corticosteroid injections (iacis) are widely
used in the management of children with juvenile idio-
pathic arthritis (JIA). Although this therapeutic interven-
tion is generally considered for the treatment of children
with arthritis in a small number of joints, the strategy of
injecting simultaneously multiple joints has been advo-
cated in children with polyarthritis. However, the rela-
tive indications of single and multiple iacis in the
management of JIA remains unclear and controversial.
Furthermore, the capacity of iacis to induce sustained
remission of synovitis in injected joints is still poorly
documented.
Objectives
To describe our 10-year experience on the use of single
and multiple iacis in the management of children with
JIA.
Methods
The clinical charts of 542 JIA patients who received an
IACI in 1,2 or ≥ 3 joints between January 2002 and
December 2011 and had a follow-up duration of at least
6 months after the procedure were reviewed. The corti-
costeroid preparation used was triamcinolone hexaceto-
nide for large joints and methylprednisolone acetate for
small or difficult to access joints. For each patient, the
follow-up period after the IACI was censored when one
of the following events occurred: 1) flare of synovitis in
injected joints; 2) flare of synovitis in injected and unin-
jected joints; 3) follow-up visit with continued remission
of synovitis in injected joints, but recurrence of synovitis
in uninjected joints; 4) last follow-up visit with contin-
ued remission of synovitis in both injected and unin-
jected joints. For the purposes of the analysis, events
1) and 2) were considered together and defined as “flare
of synovitis in injected joints”, whereas events 3) and
4) were considered together and defined as “remission
of synovitis in injected joints”.
Results
Two hundred and fifteen (39.7%) patients were injected
in 1 joint, 107 (19.7%) were injected in 2 joints and 220
(40.6%) were injected in ≥ 3 joints. Following IACI ther-
apy, 138 (25,5%) patients were in remission at last fol-
low-up visit, whereas 120 (22.1%), 93 (17.2%), and 191
(35.2%) experienced a flare of synovitis, respectively, in
uninjected joints, injected joints and either injected and
uninjected joints. The cumulative probability of survival
without synovitis flare for patients injected in 1, 2, or ≥
3 joints was 69, 46, 49%, respectively, at 1 year; 59, 31,
30%, respectively, at 2 years; and 40, 21, 19%, respec-
tively, at 3 years.
Conclusion
IACI therapy, either in single or multiple joints, was
able to induce sustained remission of synovitis in a siz-
able number of patients. Our findings indicate that iacis
remain a mainstay in the management of children with
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